Medical condition
Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma is a medical condition tracked by NovaPharmaNews across 5 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- tislelizumab (TEVIMBRA) Antineoplastic and immunomodulating agents (L01)
- ipilimumab (YERVOY) Antineoplastic and immunomodulating agents (L01)
- nivolumab (OPDIVO) Antineoplastic and immunomodulating agents (L01)
- serplulimab (HETRONIFLY) Antineoplastic and immunomodulating agents (L01)
- toripalimab (ZYTORVI) Antineoplastic and immunomodulating agents (L01)
